New Oral GLP-1 Agonist for Obesity Type 2 Diabetes

The investigational GLP-1 agonist, taken as an oral tablet, works similarly to other drugs in the class for reducing body weight and improving glucose, without needing to be taken on an empty stomach.
Medscape Medical News

source https://www.medscape.com/viewarticle/993667?src=rss